Analyst Price Target is $26.18
▲ +134.81% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Evolent Health in the last 3 months. The average price target is $26.18, with a high forecast of $41.00 and a low forecast of $15.00. The average price target represents a 134.81% upside from the last price of $11.15.
Current Consensus is
Buy
The current consensus among 12 contributing investment analysts is to buy stock in Evolent Health. This rating has held steady since July 2024, when it changed from a Moderate Buy consensus rating.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Read More